Senate Appropriations Committee Clears President’s Full MDUFMA Request
This article was originally published in The Gray Sheet
The Medical Device Manufacturers Association is appealing to AdvaMed to ponder substantive changes to MDUFMA at the larger group's board meeting in Washington, D.C. Sept. 22-23
You may also be interested in...
FDA is declining to adopt an industry proposal that would have halved the agency's projected 18% PMA user fee hike for fiscal 2005
In a statement submitted to the Senate Finance Committee, Natural Products Association CEO Dan Fabricant suggests two ways of improving compliance with new dietary ingredient notification requirements at negligible expense to the US FDA.
Public Company Edition: Legend Biotech raised $424m in its US public market debut. Also, Pfizer commits up to $500m for equity investments and Allogene capitalizes on ASCO with a $550m offering.